Now livetag icon
AI created more apps than ever, but 75% won't make it. Find out how to win. Download the reportbanner icon
Facet Biotech

May 2026

Facet Biotech Market Share Analysis for May 2026

Industry: N/A
Year Founded2008
Employees51 - 200
Annual Revenue--
facetbiotech.com
Facet Biotech
Facet Biotech (including company regionals)
  • facetbiotech.com
    facetbiotech.com
See more website traffic and engagement information

Total visits to Facet Biotech's top domains

Understand Facet Biotech market share and potential market reach.

Total visits last 3 months

No Data to Display

No Data to Display

Avg. visit duration in Facet Biotech's top domains

Analyze Facet Biotech engagement metrics.

Average visit duration last 3 months

No Data to Display

No Data to Display

Avg. pageviews on Facet Biotech's top domains

See how Facet Biotech keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

No Data to Display

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.


Facet Biotech top competitors by domain

Looks like there’s not enough data here

No Data to Display

Benchmark Your Digital Performance

Identify high-value opportunities, track your performance, and win your market.


Top technologies used by Facet Biotech

These are the website technologies, by industry, used by Facet Biotech top domains

Domain Parking (1)

Ztomy DNS

Ztomy DNS

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Facet Biotech

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAbbott acquires Facet Biotech Corporation.Due to clinical advances made in both multiple sclerosis with daclizumab and multiple myeloma with elotuzumab, Facet Biotech was acquired by Abbott Labs.

See all Facet Biotech signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.